World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
90
Citations
29215
World Ranking
2439
National Ranking
1295

Medicine

D-Index
90
Citations
29278
World Ranking
12218
National Ranking
6259

Robert Lafyatis publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Robert Lafyatis sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 304 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Robert Lafyatis D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Robert Lafyatis sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 90 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Robert Lafyatis is affiliated with the University of Pittsburgh in the United States. Their research spans across multiple fields, with a primary focus on Medicine and Biochemistry, Genetics and Molecular Biology. The scientist's work covers various subfields including Molecular Biology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Immunology, and Oncology.

Their scholarly contributions include several recent papers published in high-impact journals. These include:

  • "SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues" (2020) published in Cell
  • "Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer" (2020) published in Immunity
  • "An integrated cell atlas of the lung in health and disease" (2023) published in Nature Medicine
  • "Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung" (2021) published in Circulation
  • "Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19" (2020) published in Immunity

Robert Lafyatis has collaborated extensively, with frequent co-authors including Tracy Tabib, Eleanor Valenzi, John Sembrat, Mauricio Rojas, and Robyn T. Domsic.

The scientist's publications appear regularly in several key venues, demonstrating a broad engagement with the scientific community. These venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Annals of the Rheumatic Diseases
  • Journal of Investigative Dermatology
  • Nature Communications
  • Arthritis & Rheumatology

The main research topics explored by Lafyatis focus on complex diseases and cutting-edge molecular techniques, including:

  • Systemic Sclerosis and Related Diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Pulmonary Hypertension Research and Treatments
  • IL-33, ST2, and ILC Pathways
  • Single-cell and spatial transcriptomics
  • Extracellular vesicles in disease
  • Inflammatory Myopathies and Dermatomyositis

The subject matter expertise represented in their work reflects an integration of clinical and molecular approaches, particularly in respiratory and autoimmune conditions.

Best Publications

  • SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.

    Carly G.K. Ziegler;Samuel J. Allon;Sarah K. Nyquist;Ian M. Mbano

  • Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex.

    Seong Jin Kim;Peter Angel;Robert Lafyatis;Kazue Hattori

  • Proliferating SPP1/MERTK-expressing Macrophages in Idiopathic Pulmonary Fibrosis

    Christina Morse;Tracy Tabib;John Sembrat;Kristina L. Buschur

  • Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

    Dinesh Khanna;Christopher P Denton;Angelika Jahreis;Jacob M van Laar

  • Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

    Anthony R. Cillo;Cornelius H.L. Kürten;Cornelius H.L. Kürten;Tracy Tabib;Zengbiao Qi

  • Adaptive plasticity of IL-10 + and IL-35 + T reg cells cooperatively promotes tumor T cell exhaustion

    Deepali V Sawant;Deepali V Sawant;Hiroshi Yano;Maria Chikina;Qianxia Zhang;Qianxia Zhang

  • Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

    L. Van Bon;L. Van Bon;A. J. Affandi;A. J. Affandi;J. Broen;J. Broen;R. B. Christmann

  • Generation of Transgene‐Free Lung Disease‐Specific Human Induced Pluripotent Stem Cells Using a Single Excisable Lentiviral Stem Cell Cassette

    Aba Somers;Jyh‐Chang Jean;Cesar A. Sommer;Amel Omari

  • Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids.

    R Lafyatis;E F Remmers;A B Roberts;D E Yocum

  • Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation

    Gerald S. Horan;Susan Wood;Victor Ona;Dan Jun Li

  • Localization and actions of transforming growth factor-beta s in the embryonic nervous system.

    K.C. Flanders;G. Ludecke;S. Engels;D.S. Cissel

  • Shared and distinct mechanisms of fibrosis

    Jörg H. W. Distler;Andrea-Hermina Györfi;Meera Ramanujam;Michael L. Whitfield

  • Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system

    K. Unsicker;K.C. Flanders;D.S. Cissel;R. Lafyatis

  • A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.

    Michael R. York;Taro Nagai;Alyson J. Mangini;Raphaël Lemaire

  • Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.

    Joana P. Bernardes;Neha Mishra;Florian Tran;Thomas Bahmer

  • Transforming growth factor β—at the centre of systemic sclerosis

    Robert Lafyatis

  • Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

    Lisa M. Rice;Cristina M. Padilla;Sarah R. McLaughlin;Allison Mathes

  • B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

    Robert Lafyatis;Eugene Kissin;Michael York;Giuseppina Farina

  • Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.

    Swati Bhattacharyya;Kathleen Kelley;Denisa S. Melichian;Zenshiro Tamaki

  • SFRP2/DPP4 and FMO1/LSP1 Define Major Fibroblast Populations in Human Skin.

    Tracy Tabib;Christina Morse;Ting Wang;Wei Chen

Frequent Co-Authors

Michael L. Whitfield
Michael L. Whitfield Dartmouth College
Mauricio Rojas
Mauricio Rojas University of Pittsburgh
Ronald L. Wilder
Ronald L. Wilder National Institutes of Health
Timothy R D J Radstake
Timothy R D J Radstake Utrecht University
Michael B. Sporn
Michael B. Sporn Dartmouth College
Anita B. Roberts
Anita B. Roberts National Institutes of Health
Elaine F. Remmers
Elaine F. Remmers National Institutes of Health
Christopher P. Denton
Christopher P. Denton University College London
Maria Trojanowska
Maria Trojanowska Boston University
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Robert Lafyatis

Trending Scientists

Recently Published Articles